Back
Annaly Capital Management Vs. Viking Therapeutics Industry Stock Comparison
Sell
41
NLY
Annaly Capital Management
Last Price:
19.71
Seasonality Move:
-2.62%
Buy
53
VKTX
Viking Therapeutics
Last Price:
62.28
Seasonality Move:
10.92%
Sell
41
Annaly Capital Management (NLY)
is a Sell
Is Annaly Capital Management a Buy, Sell or Hold?
- The current Annaly Capital Management [NLY] share price is $19.70. The Score for NLY is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
- NLY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
53
Viking Therapeutics (VKTX)
is a Buy
Is Viking Therapeutics a Buy, Sell or Hold?
- The current Viking Therapeutics [VKTX] share price is $62.30. The Score for VKTX is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
- VKTX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
NLY Stock Price Chart
What is Annaly Capital Management's stock price today?
-
The Annaly Capital Management share price today is $19.70
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NLY is experiencing buying pressure, which is a positive indicator for future bullish movement.
VKTX Stock Price Chart
What is Viking Therapeutics's stock price today?
-
The Viking Therapeutics share price today is $62.30
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VKTX is experiencing slight selling pressure.
NLY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.08 | Buy |
| Relative Strength Index (14 RSI): | 53.25 | Buy |
| Chaikin Money Flow: | 4118840 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (19.16 - 20.1) | Buy |
| Bollinger Bands (100): | (18.7 - 19.82) | Buy |
VKTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.68 | Sell |
| Relative Strength Index (14 RSI): | 39.56 | Sell |
| Chaikin Money Flow: | -369406 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (64.67 - 77.83) | Sell |
| Bollinger Bands (100): | (34.63 - 80.19) | Buy |
NLY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 19.57 | Buy |
| 20-day SMA: | 19.8 | Sell |
| 50-day SMA: | 19.29 | Buy |
| 200-day SMA: | 18.9 | Buy |
| 8-day EMA: | 19.59 | Buy |
| 20-day EMA: | 19.6 | Buy |
| 50-day EMA: | 19.4 | Buy |
| 200-day EMA: | 19.31 | Buy |
VKTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 63.1 | Sell |
| 20-day SMA: | 69.99 | Sell |
| 50-day SMA: | 71.49 | Sell |
| 200-day SMA: | 35.49 | Buy |
| 8-day EMA: | 64.06 | Sell |
| 20-day EMA: | 67.39 | Sell |
| 50-day EMA: | 67.06 | Sell |
| 200-day EMA: | 44.16 | Buy |
Annaly Capital Management Earnings Growth & NLY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.02 per share, a decrease this year of $0.18 per share, and a decrease next year of $0.05 per share.
Viking Therapeutics Earnings Growth & VKTX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.18 per share, and a decrease next year of $0.44 per share.
Annaly Capital Management Technical Analysis
| May 17 | May 20 | May 21 | May 22 | May 23 | May 24 | May 28 | May 29 | May 30 | May 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 17 | 20 | 21 | 22 | 23 | 24 | 28 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Viking Therapeutics Technical Analysis
| May 17 | May 20 | May 21 | May 22 | May 23 | May 24 | May 28 | May 29 | May 30 | May 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 17 | 20 | 21 | 22 | 23 | 24 | 28 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||